Safety and Efficacy of Fludarabine and Cyclophosphamide + Rituximab

Clinical trial NCT00393107 · COMPLETED

Trial details

NCT number: NCT00393107
Sponsor: Gruppo Italiano Studio Linfomi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Follicular Lymphoma

Start date: 2000-03-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.